Detailed information for compound 377954

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 957.197 | Formula: C52H80N2O14
  • H donors: 4 H acceptors: 10 LogP: 5.17 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 2
  • SMILES: CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@H]([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H](CC[C@H]2C)C[C@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C1)C)/C)O)OC)C)C)/C)N(C(=O)C)O)C
  • InChi: 1S/C52H80N2O14/c1-30-16-12-11-13-17-31(2)41(54(64)37(8)55)28-39-21-19-36(7)52(63,68-39)49(60)50(61)53-23-15-14-18-40(53)51(62)67-44(33(4)26-38-20-22-42(56)45(27-38)65-9)29-43(57)32(3)25-35(6)47(59)48(66-10)46(58)34(5)24-30/h11-13,16-17,25,30,32-34,36,38-42,44-45,47-48,56,59,63-64H,14-15,18-24,26-29H2,1-10H3/b13-11+,16-12+,31-17+,35-25+/t30-,32-,33-,34-,36-,38+,39+,40+,41-,42-,44+,45-,47-,48+,52-/m1/s1
  • InChiKey: LOLFXEOTJYKNCJ-LILNLUPQSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis PIKK family atypical protein kinase 0.0074 0.0092 0.2269
Echinococcus multilocularis DNA dependent protein kinase catalytic subunit 0.1872 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0074 0.0092 0.2269
Toxoplasma gondii non-specific serine/threonine protein kinase 0.0082 0.0138 0.1478
Trypanosoma brucei phosphatidylinositol 4-kinase, putative 0.013 0.0405 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0074 0.0092 0.2269
Echinococcus multilocularis atpase aaa+ type core atpase aaa type core 0.0878 0.4525 0.4525
Trichomonas vaginalis conserved hypothetical protein 0.0082 0.0138 0.3411
Schistosoma mansoni phosphatidylinositol 3-and 4-kinase 0.013 0.0405 1
Giardia lamblia GTOR 0.013 0.0405 0.5
Echinococcus granulosus phosphatidylinositol 3 and 4 kinase 0.013 0.0405 0.0405
Loa Loa (eye worm) hypothetical protein 0.0082 0.0138 0.3411
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Entamoeba histolytica FKBP-rapamycin associated protein (FRAP), putative 0.013 0.0405 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0074 0.0092 0.2269
Trypanosoma cruzi hypothetical protein, conserved 0.0655 0.3294 1
Trypanosoma brucei FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative 0.0082 0.0138 0.1478
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Echinococcus granulosus FKBP12 rapamycin complex associated protein 0.013 0.0405 0.0405
Echinococcus multilocularis phosphatidylinositol 3 and 4 kinase 0.013 0.0405 0.0405
Trichomonas vaginalis PIKK family atypical protein kinase 0.0074 0.0092 0.2269
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Trypanosoma cruzi Phosphatidylinositol 3-kinase tor1 0.013 0.0405 0.0978
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0074 0.0092 0.2269
Trypanosoma cruzi target of rapamycin kinase 3 0.013 0.0405 0.0978
Toxoplasma gondii target of rapamycin (TOR), putative 0.013 0.0405 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0074 0.0092 0.2269
Trypanosoma cruzi phosphatidylinositol 3-related kinase, putative 0.013 0.0405 0.0978
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Loa Loa (eye worm) phosphatidylinositol 3 0.013 0.0405 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Trypanosoma cruzi Phosphatidylinositol 3-kinase tor2 0.013 0.0405 0.0978
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.013 0.0405 1
Schistosoma mansoni ataxia telangiectasia mutated (atm) 0.0074 0.0092 0.2269
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Echinococcus multilocularis serine protein kinase ATM 0.0074 0.0092 0.0092
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Echinococcus multilocularis tumor protein p63 0.0366 0.1703 0.1703
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Loa Loa (eye worm) phosphatidylinositol 3 0.013 0.0405 1
Trypanosoma brucei phosphatidylinositol 3-kinase, putative 0.013 0.0405 1
Echinococcus granulosus tumor protein p63 0.0366 0.1703 0.1703
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.013 0.0405 1
Schistosoma mansoni fkbp-rapamycin associated protein 0.0074 0.0092 0.2269
Echinococcus granulosus serine protein kinase ATM 0.0074 0.0092 0.0092
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Trypanosoma cruzi phosphatidylinositol 3-related kinase, putative 0.013 0.0405 0.0978
Echinococcus multilocularis FKBP12 rapamycin complex associated protein 0.013 0.0405 0.0405
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0074 0.0092 0.2269
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Schistosoma mansoni ataxia telangiectasia mutated (atm)-related 0.013 0.0405 1
Trypanosoma brucei Phosphatidylinositol 3-kinase tor1 0.013 0.0405 1
Echinococcus multilocularis serine:threonine protein kinase SMG1 0.0074 0.0092 0.0092
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Trypanosoma brucei phosphatidylinositol 3-related kinase, putative 0.013 0.0405 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Trypanosoma brucei target of rapamycin kinase 3, putative 0.013 0.0405 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0082 0.0138 0.3411
Trichomonas vaginalis PIKK family atypical protein kinase 0.0074 0.0092 0.2269
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0074 0.0092 0.2269
Entamoeba histolytica phosphatidylinositol3-kinaseTor2, putative 0.013 0.0405 1
Echinococcus granulosus serine:threonine protein kinase SMG1 0.0074 0.0092 0.0092
Loa Loa (eye worm) hypothetical protein 0.0074 0.0092 0.2269
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.013 0.0405 1
Leishmania major hypothetical protein, conserved 0.068 0.3432 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (functional) = 95 nM Inhibitory activity against human concanavalin-A proliferation assay ChEMBL. 10888319
IC50 (functional) = 95 nM Inhibitory activity against human concanavalin-A proliferation assay ChEMBL. 10888319
MIC (functional) Weak 0 ug ml-1 Compound was screened in vitro for antifungal activity against Candida albicans (CA 38247); weak ChEMBL. 10888319
MIC (functional) Weak 0 ug ml-1 Compound was screened in vitro for antifungal activity against Candida albicans (CA 62376); weak ChEMBL. 10888319
MIC (functional) Weak 0 ug ml-1 Compound was screened in vitro for antifungal activity against Candida albicans (CA 442); weak ChEMBL. 10888319
MIC (functional) = 1.56 ug ml-1 In vitro antifungal activity against T. glabrata (TG 15545) ChEMBL. 10888319
MIC (functional) = 3.12 ug ml-1 In vitro antifungal activity against Candida krusei (CK 28838) ChEMBL. 10888319
MIC (functional) = 6.25 ug ml-1 In vitro antifungal activity against Candida albicans (CA 10231) ChEMBL. 10888319
MIC (functional) = 6.25 ug ml-1 In vitro for antifungal activity against Candida albicans (CA 579a) ChEMBL. 10888319
MIC (functional) = 6.25 ug ml-1 In vitro antifungal activity against Candida tropicalis (CT 750) ChEMBL. 10888319
MIC (functional) = 6.25 ug ml-1 In vitro antifungal activity against Candida albicans (CA 10231) ChEMBL. 10888319
MIC (functional) = 6.25 ug ml-1 In vitro for antifungal activity against Candida albicans (CA 579a) ChEMBL. 10888319
MIC (functional) ~ 100 ug ml-1 Compound was screened in vitro for antifungal activity at a minimum inhibitory concentration (~100 microg/mL) against Cr. albicans (CA 34140); not affected ChEMBL. 10888319
MIC (functional) ~ 100 ug ml-1 Compound was screened in vitro for antifungal activity at a minimum inhibitory concentration (~100 microg/mL) against Aspergillus niger; not affected ChEMBL. 10888319
MIC (functional) ~ 100 ug ml-1 Compound was screened in vitro for antifungal activity at a minimum inhibitory concentration (~100 microg/mL) against Cr. albicans (CA 34140); not affected ChEMBL. 10888319

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Homo sapiens ChEMBL23 10888319

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.